Enhanced inhibition of tumor growth with depletion of CD25 regulatory cells and intratumoral immunization with tumor RNA-pulsed dendritic cells in a C57BL/6 pancreatic tumor model

Pancreas. 2009 Jul;38(5):602-4. doi: 10.1097/MPA.0b013e3181a11bde.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / administration & dosage*
  • Antibodies / immunology
  • Cell Line, Tumor
  • Combined Modality Therapy
  • Dendritic Cells / cytology
  • Dendritic Cells / immunology*
  • Dendritic Cells / transplantation
  • Female
  • Immunotherapy, Adoptive / methods
  • Interleukin-2 Receptor alpha Subunit / immunology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / therapy*
  • RNA, Neoplasm / immunology*
  • Survival Analysis
  • Time Factors
  • Treatment Outcome
  • Tumor Burden / drug effects
  • Tumor Burden / immunology

Substances

  • Antibodies
  • Interleukin-2 Receptor alpha Subunit
  • RNA, Neoplasm